Crossmark

From antiretroviral therapy access to provision of third line regimens: evidence of HIV Drug resistance mutations to first and second line regimens among Ugandan adults

Crossref DOI link: https://doi.org/10.1186/s13104-016-2309-7

Published Online: 2016-12-23

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

Namakoola, Ivan

Kasamba, Ivan

Mayanja, Billy N.

Kazooba, Patrick

Lutaakome, Joseph

Lyagoba, Fred

Kapaata, Anne A.

Kaleebu, Pontiano

Munderi, Paula
Funding

Funding for this research was provided by:

This research was jointly funded by the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordant agreement

Document is current

Any future updates will be listed below